MktsMarkets

Seres Therapeutics, Inc.
NASDAQ: MCRBKey statistics
MCRB News
Stories mentioning MCRB from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 358.00 | 351.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | |||||||
| Operating Expenses | ||||||||
| Research & Development | 13,195 | 11,684 | 12,616 | 12,939 | 11,821 | 12,840 | 16,460 | 15,806 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 21,265 | 19,815 | 22,828 | 24,881 | 27,236 | 28,836 | 29,170 | 28,871 |
| Operating Income (Loss) | (20,907) | (19,377) | (22,477) | (24,881) | (27,236) | (28,836) | (29,170) | (28,871) |
| Interest Income | 325.00 | 445.00 | 618.00 | 546.00 | 618.00 | 437.00 | 652.00 | 1,230 |
| Interest Expense | ||||||||
| Other Expense | 669.00 | 2,500 | 2,841 | 4,295 | 7,119 | 6,460 | (22,517) | 1,445 |
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (19,913) | (15,335) | 8,204 | (19,855) | 32,682 | (15,637) | 88,776 | (32,870) |
| Earnings Per Share (Basic) | (2.08) | (1.73) | 0.94 | (2.27) | 3.76 | (2.01) | 11.63 | (4.34) |
| Earnings Per Share (Diluted) | (2.08) | (1.73) | 0.94 | (2.27) | 3.75 | (2.01) | 11.63 | (4.34) |
| Weighted Average Shares Outstanding (Basic) | 9,583 | 8,859 | 8,759 | 8,744 | 8,703 | 7,770 | 7,632 | 7,576 |
| Weighted Average Shares Outstanding (Diluted) | 9,583 | 8,870 | 8,772 | 8,744 | 8,715 | 7,770 | 7,632 | 7,576 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MCRB
Seres Therapeutics, Inc. (NASDAQ: MCRB) is a stock listed on the Nasdaq Stock Market under the ticker symbol MCRB. It last traded at $2.09 (Oct 23, 2026, 4:00 PM ET), down 1.9% on the day. That gives Seres Therapeutics a market capitalisation of $20.8M.
Over the past 52 weeks MCRB has traded between $2.00 and $29.98.
Revenue for the quarter ended Mar 31, 2026 was $358.0K; a net loss of $19.9M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $358.0K | -$19.9M | -5562.3% |
| Dec 31, 2025 | — | -$15.3M | — |
| Sep 30, 2025 | $351.0K | $8.2M | 2337.3% |
| Jun 30, 2025 | — | -$19.9M | — |
From Seres Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…